Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The return on equity (ROE) is N/A as of the fiscal period ended Tuesday, March 31, 2026.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q1 FY2026 (2026-03-31): -329.43%.
RETURN ON EQUITY (ROE)
N/A
RETURN ON EQUITY (ROE) AVG TTM
-81.43%
RETURN ON EQUITY (ROE) AVG 3Y
-44.84%
RETURN ON EQUITY (ROE) AVG 5Y
-58.58%
RETURN ON EQUITY (ROE) AVG 10Y
N/A
RETURN ON EQUITY (ROE) AVG 15Y
N/A
RETURN ON EQUITY (ROE) AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Mirum Pharmaceuticals, Inc.
Market Cap
$4.85B
Return on Equity (ROE)
N/A
TTM Avg
-81.43%
3Y Avg
-44.84%
5Y Avg
-58.58%
Market Cap
$4.82B
Return on Equity (ROE)
-11.92%
TTM Avg
-22.12%
3Y Avg
-20.62%
5Y Avg
-23.54%
Market Cap
$4.71B
Return on Equity (ROE)
-2.55%
TTM Avg
-28.50%
3Y Avg
-30.36%
5Y Avg
-30.19%
Market Cap
$4.67B
Return on Equity (ROE)
3.43%
TTM Avg
-1.67%
3Y Avg
-7.64%
5Y Avg
-9.04%
Market Cap
$4.66B
Return on Equity (ROE)
-38.51%
TTM Avg
-50.16%
3Y Avg
-65.11%
5Y Avg
-61.13%
Market Cap
$4.66B
Return on Equity (ROE)
16.63%
TTM Avg
15.37%
3Y Avg
15.09%
5Y Avg
11.91%
Market Cap
$5.07B
Return on Equity (ROE)
8.67%
TTM Avg
8.42%
3Y Avg
7.80%
5Y Avg
5.80%
Market Cap
$5.08B
Return on Equity (ROE)
-79.37%
TTM Avg
-38.23%
3Y Avg
-43.73%
5Y Avg
-49.41%
Market Cap
$5.09B
Return on Equity (ROE)
-161.00%
TTM Avg
-110.38%
3Y Avg
-86.51%
5Y Avg
-75.97%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Mirum Pharmaceuticals, Inc. (MIRM) | $4.85B | N/A | -81.43% | -44.84% | -58.58% |
| Oruka Therapeutics, Inc. (ORKA)vs › | $4.82B | -11.92% | -22.12% | -20.62% | -23.54% |
| Dianthus Therapeutics, Inc. (DNTH)vs › | $4.71B | -2.55% | -28.50% | -30.36% | -30.19% |
| LifeStance Health Group, Inc. (LFST)vs › | $4.67B | 3.43% | -1.67% | -7.64% | -9.04% |
| Definium Therapeutics, Inc. (DFTX)vs › | $4.66B | -38.51% | -50.16% | -65.11% | -61.13% |
| Option Care Health, Inc. (OPCH)vs › | $4.66B | 16.63% | 15.37% | 15.09% | 11.91% |
| Merit Medical Systems, Inc. (MMSI)vs › | $5.07B | 8.67% | 8.42% | 7.80% | 5.80% |
| Erasca, Inc. (ERAS)vs › | $5.08B | -79.37% | -38.23% | -43.73% | -49.41% |
| Scholar Rock Holding Corporation (SRRK)vs › | $5.09B | -161.00% | -110.38% | -86.51% | -75.97% |
| BillionToOne, Inc. (BLLN)vs › | $4.63B | 6.24% | -11.62% | -98.18% | -98.18% |
ROE
N/A
ROA
-82.3%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-03-31 | -329.43% |
| 2025-12-31 | -7.42% |
| 2025-09-30 | -14.18% |
| 2025-06-30 | -22.95% |
| 2025-03-31 | -33.16% |
| 2024-12-31 | -38.97% |
| 2024-09-30 | -43.02% |
| 2024-06-30 | -47.67% |
| 2024-03-31 | -67.59% |
| 2023-12-31 | -65.72% |
| 2023-09-30 | -61.02% |
| 2023-06-30 | -224.28% |
| 2023-03-31 | -91.53% |
| 2022-12-31 | -95.51% |
| 2022-09-30 | -24.62% |
| 2022-06-30 | -47.96% |
| 2022-03-31 | -64.32% |
| 2021-12-31 | -69.87% |
| 2021-09-30 | -316.93% |
| 2021-06-30 | -159.95% |
| 2021-03-31 | -98.96% |
| 2020-12-31 | -60.01% |
| 2020-09-30 | -69.87% |
| 2020-06-30 | -56.97% |
| 2020-03-31 | -43.50% |
| 2019-12-31 | -40.32% |
| 2019-09-30 | -41.41% |
